Comparison 9. Ustekinumab vs placebo.
Outcome or subgroup title | No. of studies | No. of participants | Statistical method | Effect size |
---|---|---|---|---|
1 Proportion of participants achieving a 50% reduction in disease severity in the short term | 1 | 33 | Risk Ratio (M‐H, Random, 95% CI) | 0.48 [0.11, 2.13] |